Annual D&A
$3.24 B
-$24.00 M-0.73%
31 December 2023
Summary:
Abbott Laboratories annual depreciation & amortization is currently $3.24 billion, with the most recent change of -$24.00 million (-0.73%) on 31 December 2023. During the last 3 years, it has fallen by -$84.00 million (-2.52%). ABT annual D&A is now -8.34% below its all-time high of $3.54 billion, reached on 31 December 2021.ABT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$801.00 M
-$4.00 M-0.50%
30 September 2024
Summary:
Abbott Laboratories quarterly depreciation & amortization is currently $801.00 million, with the most recent change of -$4.00 million (-0.50%) on 30 September 2024. Over the past year, it has dropped by -$23.00 million (-2.79%). ABT quarterly D&A is now -14.24% below its all-time high of $934.00 million, reached on 31 March 2021.ABT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$3.22 B
-$23.00 M-0.71%
30 September 2024
Summary:
Abbott Laboratories TTM depreciation & amortization is currently $3.22 billion, with the most recent change of -$23.00 million (-0.71%) on 30 September 2024. Over the past year, it has dropped by -$13.00 million (-0.40%). ABT TTM D&A is now -8.88% below its all-time high of $3.54 billion, reached on 31 December 2021.ABT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -0.7% | -2.8% | -0.4% |
3 y3 years | -2.5% | -5.4% | -8.4% |
5 y5 years | -1.1% | +6.2% | +6.7% |
ABT Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -8.3% | at low | -9.3% | +0.1% | -8.9% | at low |
5 y | 5 years | -8.3% | +7.6% | -14.2% | +6.2% | -8.9% | +7.0% |
alltime | all time | -8.3% | +955.3% | -14.2% | +829.2% | -8.9% | +3538.8% |
Abbott Laboratories Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $801.00 M(-0.5%) | $3.22 B(-0.7%) |
June 2024 | - | $805.00 M(0.0%) | $3.25 B(+0.2%) |
Mar 2024 | - | $805.00 M(-1.0%) | $3.24 B(-0.0%) |
Dec 2023 | $3.24 B(-0.7%) | $813.00 M(-1.3%) | $3.24 B(+0.2%) |
Sept 2023 | - | $824.00 M(+3.0%) | $3.24 B(+0.3%) |
June 2023 | - | $800.00 M(-0.7%) | $3.23 B(-0.7%) |
Mar 2023 | - | $806.00 M(-0.1%) | $3.25 B(-0.5%) |
Dec 2022 | $3.27 B(-7.7%) | $807.00 M(-1.0%) | $3.27 B(-2.3%) |
Sept 2022 | - | $815.00 M(-0.9%) | $3.34 B(-0.9%) |
June 2022 | - | $822.00 M(-0.1%) | $3.38 B(-1.5%) |
Mar 2022 | - | $823.00 M(-6.8%) | $3.43 B(-3.1%) |
Dec 2021 | $3.54 B(+6.3%) | $883.00 M(+4.3%) | $3.54 B(+0.5%) |
Sept 2021 | - | $847.00 M(-3.1%) | $3.52 B(+1.1%) |
June 2021 | - | $874.00 M(-6.4%) | $3.48 B(+1.4%) |
Mar 2021 | - | $934.00 M(+7.9%) | $3.43 B(+3.2%) |
Dec 2020 | $3.33 B(+10.4%) | $866.00 M(+7.2%) | $3.33 B(+3.4%) |
Sept 2020 | - | $808.00 M(-2.1%) | $3.22 B(+1.7%) |
June 2020 | - | $825.00 M(-0.4%) | $3.16 B(+2.4%) |
Mar 2020 | - | $828.00 M(+9.5%) | $3.09 B(+2.5%) |
Dec 2019 | $3.01 B(-8.1%) | $756.00 M(+0.3%) | $3.01 B(-0.2%) |
Sept 2019 | - | $754.00 M(+0.4%) | $3.02 B(-1.9%) |
June 2019 | - | $751.00 M(-0.3%) | $3.08 B(-3.1%) |
Mar 2019 | - | $753.00 M(-1.3%) | $3.18 B(-3.0%) |
Dec 2018 | $3.28 B(+8.5%) | $763.00 M(-6.2%) | $3.28 B(-2.4%) |
Sept 2018 | - | $813.00 M(-4.4%) | $3.36 B(+1.7%) |
June 2018 | - | $850.00 M(-0.2%) | $3.30 B(+6.5%) |
Mar 2018 | - | $852.00 M(+1.1%) | $3.10 B(+2.6%) |
Dec 2017 | $3.02 B(+123.3%) | $843.00 M(+11.5%) | $3.02 B(+21.0%) |
Sept 2017 | - | $756.00 M(+16.7%) | $2.50 B(+20.0%) |
June 2017 | - | $648.00 M(-16.3%) | $2.08 B(+16.9%) |
Mar 2017 | - | $774.00 M(+142.6%) | $1.78 B(+31.6%) |
Dec 2016 | $1.35 B(-8.1%) | $319.00 M(-6.2%) | $1.35 B(-3.4%) |
Sept 2016 | - | $340.00 M(-2.0%) | $1.40 B(-3.0%) |
June 2016 | - | $347.00 M(0.0%) | $1.44 B(-0.3%) |
Mar 2016 | - | $347.00 M(-5.2%) | $1.45 B(-1.6%) |
Dec 2015 | $1.47 B(-4.9%) | $366.00 M(-4.4%) | $1.47 B(-1.9%) |
Sept 2015 | - | $383.00 M(+8.8%) | $1.50 B(+1.9%) |
June 2015 | - | $352.00 M(-5.1%) | $1.47 B(-3.2%) |
Mar 2015 | - | $371.00 M(-6.1%) | $1.52 B(-1.7%) |
Dec 2014 | $1.55 B(-9.9%) | $395.00 M(+11.3%) | $1.55 B(-2.0%) |
Sept 2014 | - | $355.00 M(-11.3%) | $1.58 B(-4.9%) |
June 2014 | - | $400.00 M(+0.5%) | $1.66 B(-2.1%) |
Mar 2014 | - | $398.00 M(-6.6%) | $1.70 B(-1.3%) |
Dec 2013 | $1.72 B(-38.2%) | $426.00 M(-2.3%) | $1.72 B(-8.6%) |
Sept 2013 | - | $436.00 M(0.0%) | $1.88 B(-14.7%) |
June 2013 | - | $436.00 M(+3.6%) | $2.20 B(-10.4%) |
Mar 2013 | - | $421.00 M(-28.3%) | $2.46 B(-11.6%) |
Dec 2012 | $2.78 B(-8.6%) | $587.57 M(-22.7%) | $2.78 B(-2.1%) |
Sept 2012 | - | $759.73 M(+9.9%) | $2.84 B(-2.7%) |
June 2012 | - | $691.43 M(-7.0%) | $2.92 B(-3.9%) |
Mar 2012 | - | $743.27 M(+14.6%) | $3.04 B(-0.1%) |
Dec 2011 | $3.04 B(+16.0%) | $648.53 M(-22.6%) | $3.04 B(-2.0%) |
Sept 2011 | - | $838.39 M(+3.3%) | $3.11 B(+5.5%) |
June 2011 | - | $811.41 M(+8.8%) | $2.94 B(+4.9%) |
Mar 2011 | - | $745.67 M(+5.1%) | $2.81 B(+7.0%) |
Dec 2010 | $2.62 B(+25.6%) | $709.58 M(+4.8%) | $2.62 B(+6.6%) |
Sept 2010 | - | $677.02 M(+0.3%) | $2.46 B(+5.9%) |
June 2010 | - | $675.20 M(+20.0%) | $2.33 B(+6.3%) |
Mar 2010 | - | $562.50 M(+2.8%) | $2.19 B(+4.7%) |
Dec 2009 | $2.09 B(+13.6%) | $547.35 M(+1.2%) | $2.09 B(+6.4%) |
Sept 2009 | - | $540.71 M(+0.6%) | $1.96 B(+2.2%) |
June 2009 | - | $537.40 M(+15.8%) | $1.92 B(+3.9%) |
Mar 2009 | - | $464.05 M(+9.8%) | $1.85 B(+0.7%) |
Dec 2008 | $1.84 B(-0.9%) | $422.56 M(-15.2%) | $1.84 B(-3.2%) |
Sept 2008 | - | $498.56 M(+7.0%) | $1.90 B(-0.3%) |
June 2008 | - | $465.86 M(+3.1%) | $1.90 B(+1.6%) |
Mar 2008 | - | $451.85 M(-6.5%) | $1.87 B(+1.0%) |
Dec 2007 | $1.85 B | $483.19 M(-4.1%) | $1.85 B(+4.0%) |
Sept 2007 | - | $503.77 M(+15.7%) | $1.78 B(+7.4%) |
June 2007 | - | $435.50 M(+0.7%) | $1.66 B(+2.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $432.42 M(+5.2%) | $1.62 B(+3.8%) |
Dec 2006 | $1.56 B(+14.7%) | $411.11 M(+7.8%) | $1.56 B(+4.9%) |
Sept 2006 | - | $381.44 M(-3.1%) | $1.49 B(+2.6%) |
June 2006 | - | $393.61 M(+5.6%) | $1.45 B(+4.4%) |
Mar 2006 | - | $372.59 M(+10.3%) | $1.39 B(+2.0%) |
Dec 2005 | $1.36 B(+5.5%) | $337.71 M(-1.6%) | $1.36 B(+0.3%) |
Sept 2005 | - | $343.37 M(+3.1%) | $1.35 B(+2.3%) |
June 2005 | - | $332.98 M(-3.5%) | $1.32 B(-1.5%) |
Mar 2005 | - | $344.88 M(+3.5%) | $1.34 B(+4.3%) |
Dec 2004 | $1.29 B(+14.3%) | $333.36 M(+6.6%) | $1.29 B(+0.5%) |
Sept 2004 | - | $312.80 M(-11.4%) | $1.28 B(+6.2%) |
June 2004 | - | $353.24 M(+22.1%) | $1.21 B(+9.3%) |
Mar 2004 | - | $289.30 M(-11.4%) | $1.10 B(-2.1%) |
Dec 2003 | $1.13 B(+8.0%) | $326.54 M(+37.4%) | $1.13 B(+18.3%) |
Sept 2003 | - | $237.66 M(-5.2%) | $953.01 M(-5.3%) |
June 2003 | - | $250.59 M(-19.9%) | $1.01 B(-2.5%) |
Mar 2003 | - | $312.65 M(+105.5%) | $1.03 B(-1.0%) |
Dec 2002 | $1.04 B(-10.7%) | $152.11 M(-47.8%) | $1.04 B(-13.8%) |
Sept 2002 | - | $291.46 M(+5.2%) | $1.21 B(-1.3%) |
June 2002 | - | $276.93 M(-14.3%) | $1.23 B(-2.7%) |
Mar 2002 | - | $323.12 M(+1.3%) | $1.26 B(+8.0%) |
Dec 2001 | $1.17 B(+41.2%) | $318.89 M(+3.6%) | $1.17 B(+11.5%) |
Sept 2001 | - | $307.87 M(-1.1%) | $1.05 B(+12.3%) |
June 2001 | - | $311.19 M(+35.3%) | $932.91 M(+5.4%) |
Mar 2001 | - | $230.07 M(+15.7%) | $884.94 M(+7.0%) |
Dec 2000 | $827.43 M(-0.1%) | $198.78 M(+3.1%) | $827.43 M(+0.6%) |
Sept 2000 | - | $192.88 M(-26.7%) | $822.62 M(-2.8%) |
June 2000 | - | $263.21 M(+52.5%) | $846.27 M(+7.3%) |
Mar 2000 | - | $172.56 M(-11.0%) | $788.35 M(-4.8%) |
Dec 1999 | $828.00 M(+5.3%) | $193.97 M(-10.4%) | $828.00 M(-0.2%) |
Sept 1999 | - | $216.53 M(+5.5%) | $829.43 M(+2.3%) |
June 1999 | - | $205.29 M(-3.3%) | $810.60 M(+0.3%) |
Mar 1999 | - | $212.21 M(+8.6%) | $808.01 M(+2.7%) |
Dec 1998 | $786.40 M(+7.9%) | $195.40 M(-1.2%) | $786.40 M(+1.7%) |
Sept 1998 | - | $197.70 M(-2.5%) | $773.10 M(-0.1%) |
June 1998 | - | $202.70 M(+6.3%) | $773.97 M(+4.1%) |
Mar 1998 | - | $190.60 M(+4.7%) | $743.62 M(+2.0%) |
Dec 1997 | $729.10 M(+6.3%) | $182.10 M(-8.3%) | $729.10 M(+0.6%) |
Sept 1997 | - | $198.56 M(+15.2%) | $725.04 M(+1.4%) |
June 1997 | - | $172.36 M(-2.1%) | $715.24 M(+2.3%) |
Mar 1997 | - | $176.08 M(-1.1%) | $698.88 M(+1.9%) |
Dec 1996 | $686.10 M(+21.1%) | $178.04 M(-5.7%) | $686.10 M(+1.6%) |
Sept 1996 | - | $188.76 M(+21.0%) | $674.99 M(+7.9%) |
June 1996 | - | $156.00 M(-4.5%) | $625.44 M(+5.5%) |
Mar 1996 | - | $163.30 M(-2.2%) | $592.64 M(+4.6%) |
Dec 1995 | $566.42 M(+11.0%) | $166.93 M(+19.9%) | $566.42 M(+9.1%) |
Sept 1995 | - | $139.21 M(+13.0%) | $518.95 M(+1.7%) |
June 1995 | - | $123.20 M(-10.1%) | $510.34 M(-1.0%) |
Mar 1995 | - | $137.08 M(+14.8%) | $515.25 M(+0.9%) |
Dec 1994 | $510.50 M(+5.5%) | $119.45 M(-8.5%) | $510.50 M(+2.3%) |
Sept 1994 | - | $130.60 M(+1.9%) | $498.83 M(+1.2%) |
June 1994 | - | $128.11 M(-3.2%) | $492.93 M(-0.8%) |
Mar 1994 | - | $132.34 M(+22.8%) | $497.12 M(+2.7%) |
Dec 1993 | $484.08 M(+13.2%) | $107.78 M(-13.6%) | $484.08 M(+2.4%) |
Sept 1993 | - | $124.70 M(-5.7%) | $472.60 M(+2.9%) |
June 1993 | - | $132.30 M(+10.9%) | $459.40 M(+5.8%) |
Mar 1993 | - | $119.30 M(+23.9%) | $434.20 M(+1.5%) |
Dec 1992 | $427.80 M(+12.9%) | $96.30 M(-13.6%) | $427.80 M(+1.0%) |
Sept 1992 | - | $111.50 M(+4.1%) | $423.40 M(+4.3%) |
June 1992 | - | $107.10 M(-5.1%) | $406.10 M(+2.9%) |
Mar 1992 | - | $112.90 M(+22.9%) | $394.50 M(+4.1%) |
Dec 1991 | $379.00 M(+6.5%) | $91.90 M(-2.4%) | $379.00 M(-0.6%) |
Sept 1991 | - | $94.20 M(-1.4%) | $381.10 M(+2.1%) |
June 1991 | - | $95.50 M(-2.0%) | $373.10 M(+2.3%) |
Mar 1991 | - | $97.40 M(+3.6%) | $364.70 M(+2.5%) |
Dec 1990 | $355.90 M(+15.8%) | $94.00 M(+9.0%) | $355.90 M(+35.9%) |
Sept 1990 | - | $86.20 M(-1.0%) | $261.90 M(+49.1%) |
June 1990 | - | $87.10 M(-1.7%) | $175.70 M(+98.3%) |
Mar 1990 | - | $88.60 M | $88.60 M |
Dec 1989 | $307.30 M | - | - |
FAQ
- What is Abbott Laboratories annual depreciation & amortization?
- What is the all time high annual D&A for Abbott Laboratories?
- What is Abbott Laboratories annual D&A year-on-year change?
- What is Abbott Laboratories quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Abbott Laboratories?
- What is Abbott Laboratories quarterly D&A year-on-year change?
- What is Abbott Laboratories TTM depreciation & amortization?
- What is the all time high TTM D&A for Abbott Laboratories?
- What is Abbott Laboratories TTM D&A year-on-year change?
What is Abbott Laboratories annual depreciation & amortization?
The current annual D&A of ABT is $3.24 B
What is the all time high annual D&A for Abbott Laboratories?
Abbott Laboratories all-time high annual depreciation & amortization is $3.54 B
What is Abbott Laboratories annual D&A year-on-year change?
Over the past year, ABT annual depreciation & amortization has changed by -$24.00 M (-0.73%)
What is Abbott Laboratories quarterly depreciation & amortization?
The current quarterly D&A of ABT is $801.00 M
What is the all time high quarterly D&A for Abbott Laboratories?
Abbott Laboratories all-time high quarterly depreciation & amortization is $934.00 M
What is Abbott Laboratories quarterly D&A year-on-year change?
Over the past year, ABT quarterly depreciation & amortization has changed by -$23.00 M (-2.79%)
What is Abbott Laboratories TTM depreciation & amortization?
The current TTM D&A of ABT is $3.22 B
What is the all time high TTM D&A for Abbott Laboratories?
Abbott Laboratories all-time high TTM depreciation & amortization is $3.54 B
What is Abbott Laboratories TTM D&A year-on-year change?
Over the past year, ABT TTM depreciation & amortization has changed by -$13.00 M (-0.40%)